Faes Farma (Faes Farma) 3-Year EBITDA Growth Rate : 4.70% (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Faes Farma 3-Year EBITDA Growth Rate?

Faes Farma's EBITDA per Share for the three months ended in Jun. 2023 was $0.14.

During the past 12 months, Faes Farma's average EBITDA Per Share Growth Rate was -0.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Faes Farma was 16.60% per year. The lowest was -13.70% per year. And the median was 9.60% per year.

Competitive Comparison of Faes Farma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Faes Farma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Faes Farma's 3-Year EBITDA Growth Rate falls into.

Faes Farma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Faes Farma (OTCPK:FSXMF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Faes Farma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Faes Farma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (Faes Farma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (OTCPK:FSXMF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0K9H:UK FAE:Spain FFEA:Germany

Address

Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940

Website

http://www.faes.es

Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (Faes Farma) Headlines

No Headlines